HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

HIV prevention | Image credit: magann - stock.adobe.com
CDC Updates Guidelines for Use of Nonoccupational PEP

May 8th 2025

These guidelines act as an update to the 2016 guidelines for the use of nonoccupational postexposure prophylaxis (PEP) after exposure to HIV.

Woman with HIV awareness ribbon | Image credit: Krakenimages.com - stock.adobe.com
Women With 90% ART Adherence More Likely to Report Viral Suppression

May 6th 2025

Illicit drugs | Image credit: Stanislau_V - stock.adobe.com
SDOH Domains at Risk Correlated With Substance Use in People With HIV

May 2nd 2025

HIV | Image credit: reddish - stock.adobe.com
Family Dynamics, Mental Health Influence Adherence to ART

April 29th 2025

Richard Hughes IV, JD, MPH
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV

April 21st 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
May 9th 2025

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

Janssen Releases New Data Confirming Safety and Efficacy of Symtuza for HIV
August 9th 2018

Janssen Releases New Data Confirming Safety and Efficacy of Symtuza for HIV

Jaime Rosenberg
A month after Symtuza's approval, Janssen announced new switch data on the treatment and a second study supporting its use in a rapid initiation scenario.
PEPFAR, Elton John Reaffirm Commitment to, Investment in HIV Support for Key Populations
August 3rd 2018

PEPFAR, Elton John Reaffirm Commitment to, Investment in HIV Support for Key Populations

Jaime Rosenberg
During the 2018 International AIDS Conference, the US President’s Emergency Plan for AIDS Relief (PEPFAR) and the Elton John AIDS Foundation revealed initial results from the LGBT Fund, which they launched in 2016. PEPFAR also announced over $360 million in funding over the next 12 months.
Neurological Disabilities More Likely in Children With HIV
August 2nd 2018

Neurological Disabilities More Likely in Children With HIV

Jaime Rosenberg
Developmental issues, such as impaired brain growth, are more likely to occur in children with HIV than those without the virus.
Podcast: This Week in Managed Care—CMS to Resume Risk Adjustment Payments and Other Health News
July 28th 2018

Podcast: This Week in Managed Care—CMS to Resume Risk Adjustment Payments and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This Week in Managed Care: July 27, 2018
July 27th 2018

This Week in Managed Care: July 27, 2018

This week, the top managed care stories included CMS reversing its decision to suspend the risk adjustment payment program; out-of-pocket costs and copayment accumulators put an HIV prevention drug out of reach for patients; research finds geography can determine posttreatment imaging for women with breast cancer.
HIV Comorbidities Associated With More Hospitalizations, Increased Costs
July 26th 2018

HIV Comorbidities Associated With More Hospitalizations, Increased Costs

Jaime Rosenberg
As people living with HIV now have a normal life expectancy, thanks to antiretroviral therapy, the burden of comorbidities is on the rise, and more than half of deaths in the patient population are attributable to these comorbidities.
PrEP for HIV Prevention: Essential for Ending the Epidemic, but Out of Reach for Many
July 24th 2018

PrEP for HIV Prevention: Essential for Ending the Epidemic, but Out of Reach for Many

Jaime Rosenberg
Despite pre-exposure prophylaxis (PrEP) being crucial for preventing new HIV infections and working toward an end to the epidemic, the treatment is still out of reach for many.
Urgent Change in Approach to HIV Pandemic Is Needed, Report Says
July 20th 2018

Urgent Change in Approach to HIV Pandemic Is Needed, Report Says

Jaime Rosenberg
According to a report, existing HIV tools and strategies are insufficient, and despite historic breakthroughs in maximizing prevention and treatment strategies, the HIV pandemic will likely continue to be a global challenge for the foreseeable future.
FDA Approves First Darunavir-Based Single-Tablet Regimen for HIV
July 18th 2018

FDA Approves First Darunavir-Based Single-Tablet Regimen for HIV

Jaime Rosenberg
Janssen announced the approval of Symtuza (darunavir 800 mg, cobistat 150 mg, emtricitabine 200 mg, and tenofovir alafenamide 10 mg) for the treatment of HIV-1 in treatment-naïve and certain virologically suppressed patients.
MANNA: Providing Nutritious Meals and a Sense of Community to People Living With HIV
July 13th 2018

MANNA: Providing Nutritious Meals and a Sense of Community to People Living With HIV

Jaime Rosenberg
Since 1990, MANNA has been providing nourishing meals and a sense of community to people living with HIV and other chronic diseases in Philadelphia.
Site Logo
July 13th 2018

Modeling the Impacts of Restrictive Formularies on Patients With HIV

James Baumgardner, PhD Caroline Huber, MPH Mina Kabiri, PhD Lara Yoon, MPH Jacki Chou, MPP, MPL John Romley, PhD
Constraining access to HIV regimens can have significant implications for patients. This study examined the economic and health impacts of restrictive HIV formulary designs.
Mobile Health Intervention for HIV Improves Retention in Care, Patient Outcomes
July 11th 2018

Mobile Health Intervention for HIV Improves Retention in Care, Patient Outcomes

Jaime Rosenberg
Through the use of a smartphone app, researchers observed that participants became more engaged with their HIV care, resulting in improved linkage to and consistency of care, increased CD4 counts, and decreased viral loads.
HIV Vaccine Candidate Proves Safe, Induces Immune Response in Healthy Adults, Monkeys
July 7th 2018

HIV Vaccine Candidate Proves Safe, Induces Immune Response in Healthy Adults, Monkeys

Jaime Rosenberg
Research results from 2 studies found that the mosaic Ad26–based HIV vaccine regimens were both well-tolerated and induced a robust immune response against HIV in healthy adults and rhesus monkeys.
This Week in Managed Care: July 6, 2018
July 6th 2018

This Week in Managed Care: July 6, 2018

This week, the top managed care stories included a federal judge blocking Kentucky’s Medicaid work requirements; CMS announced it would launch a demonstration to encourage Medicare Advantage providers to take on more risk; and researchers identify racial disparities in HIV incidence and recommended a 5-part plan of action.
Site Logo
July 5th 2018

Study Summary: Impact of Same-Day HIV Testing and ART Initiation on Patient Care and Outcomes

Koenig SP, Dorvil N, D
Site Logo
July 5th 2018

Study Summary: Effect of Comorbid MDD on HIV Disease Profression

Owora AH. Major depression disorder trajectories, HIV disease progression: results from a 6-year outpatient clinic cohort. Medicine (Baltimore). 2018, 97(12):e0252. doi: 10.1097/MD.0000000000010252.
Site Logo
July 5th 2018

Study Summary: Risk of Mother-to-Baby-HIV Trasmission Among Mothers Coinfected with Other STIs

Adachi K, Xu J, Yeganeh N, et al, NICHD HPTN 040 Study Team. Combined evaluation of sexually transmitted infections in HIV-infected pregnant women, infant HIV transmission. PLoS One. 2018, 13(1):e0189851. doi: 10.1371/journal.pone.0189851.
Identifying Missed Opportunities for HIV Testing in Clinical Settings
July 3rd 2018

Identifying Missed Opportunities for HIV Testing in Clinical Settings

Jaime Rosenberg
Pinpointing and eliminating missed opportunities for HIV testing and diagnosis in healthcare settings has the potential to reduce HIV transmission, especially among high-risk groups.
What We're Reading: Trauma Fees Inflate ED Bills; CDC Chief Switches View; Painkiller Shortages in Hospitals
July 2nd 2018

What We're Reading: Trauma Fees Inflate ED Bills; CDC Chief Switches View; Painkiller Shortages in Hospitals

AJMC Staff
Collected emergency department (ED) bills show that trauma fees are costly and swing widely; the head of the CDC has changed his mind about opposing the use of condoms and needle programs as ways to stop the spread of sexually transmitted diseases; EDs around the country are struggling with shortages of painkillers and cardiac drugs.
Researchers Highlight Disproportionate HIV Incidence Among African Americans, Recommend Plan of Action
June 29th 2018

Researchers Highlight Disproportionate HIV Incidence Among African Americans, Recommend Plan of Action

Jaime Rosenberg
African Americans are still disproportionately affected by HIV compared with other ethnic groups.
Increasing Awareness and Early Diagnosis on National HIV Testing Day
June 27th 2018

Increasing Awareness and Early Diagnosis on National HIV Testing Day

Jaime Rosenberg
As tomorrow marks National HIV Testing Day, over 400 organizations and clinics nationwide are spearheading efforts to promote testing.
Many People at Risk of Contracting HIV Are Not Screened Annually
June 24th 2018

Many People at Risk of Contracting HIV Are Not Screened Annually

Jaime Rosenberg
Many people at high risk of getting HIV—including those who inject drugs, gay and bisexual men, and partners of people with HIV—are not screened annually and experience delays in diagnosis.
Viral Suppression in People With HIV Associated With Reduced Cancer Risk
June 21st 2018

Viral Suppression in People With HIV Associated With Reduced Cancer Risk

Jaime Rosenberg
For people living with HIV who achieve viral suppression from antiretroviral therapy, there is a reduced risk of developing both AIDS-defining cancer and non-AIDS-defining cancer.
Walgreens, Greater Than AIDS Team Up With Health Organizations to Provide Free HIV Testing
June 13th 2018

Walgreens, Greater Than AIDS Team Up With Health Organizations to Provide Free HIV Testing

Jaime Rosenberg
On National HIV Testing Day on June 27, Walgreens and Greater Than AIDS will partner with over 200 health and community organizations to provide free HIV testing and information at Walgreens stores in over 180 cities.
NCI-Designated Cancer Centers Endorse Goal of Eliminating HPV-Related Cancers
June 13th 2018

NCI-Designated Cancer Centers Endorse Goal of Eliminating HPV-Related Cancers

Jaime Rosenberg
The 70 National Cancer Institute (NCI)-designated cancer centers underscored the importance of increased HPV vaccination and evidence-based screening, with the goal of eliminating cancers caused by the human papillomavirus (HPV).
Early ART Initiation Significantly Reduces Treatment Failure in Patients With HIV
June 8th 2018

Early ART Initiation Significantly Reduces Treatment Failure in Patients With HIV

Jaime Rosenberg
New study results have concluded that antiretroviral therapy (ART) initiation within 30 days of HIV diagnosis is associated with a significantly reduced risk of treatment dropout and failure.
Successful Management of HIV Is Outpacing That of Diabetes in Women
June 7th 2018

Successful Management of HIV Is Outpacing That of Diabetes in Women

Jaime Rosenberg
Among HIV-positive women with diabetes, HIV control has improved over time, but diabetes control has not.
PEPFAR Reaches 14 Million People With HIV Globally
May 31st 2018

PEPFAR Reaches 14 Million People With HIV Globally

Jaime Rosenberg
As this month marks the 15th anniversary, the US President’s Emergency Plan for AIDS Relief (PEPFAR) now supports over 14 million people globally with HIV treatment.
Study Will Assess Safety of HIV-to-HIV Kidney Transplantation
May 29th 2018

Study Will Assess Safety of HIV-to-HIV Kidney Transplantation

Jaime Rosenberg
The HOPE in Action Multicenter Kidney Study will examine the safety of HIV-to-HIV kidney transplantation.
Podcast: This Week in Managed Care—Impact of Hypertension Guideline Update and Other Health News
May 26th 2018

Podcast: This Week in Managed Care—Impact of Hypertension Guideline Update and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
<1
...
212223242526272829
...
32>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo